Quick answers
- What is Omadacycline used for?
- The FDA-approved label (Nuzyra, Paratek Pharmaceuticals, Inc., May 27, 2026) says: “NUZYRA is a tetracycline class antibacterial indicated for the treatment of adult patients with the following infections caused by susceptible microorganisms: Community-acquired bacterial pneumonia (CABP) Acute bacterial skin and skin structure infections (ABSSSI) To reduce the development of drug-resistant bacteria and maintain the effectiveness of NUZYRA and other antibacterial drugs, NUZYRA should be used only to …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Omadacycline have a boxed warning?
- No. None of the 1 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Omadacycline?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Omadacycline been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Omadacycline?
- 1 company lists prescription products of Omadacycline in the FDA NDC Directory, including Paratek Pharmaceuticals, Inc..
What Omadacycline is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
NUZYRA is a tetracycline class antibacterial indicated for the treatment of adult patients with the following infections caused by susceptible microorganisms: Community-acquired bacterial pneumonia (CABP) Acute bacterial skin and skin structure infections (ABSSSI) To reduce the development of drug-resistant bacteria and maintain the effectiveness of NUZYRA and other antibacterial drugs, NUZYRA should be used only to …
— FDA label: Nuzyra, Paratek Pharmaceuticals, Inc., effective May 27, 2026. Read the full label on DailyMed →
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Conditions named on the label
These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.
Related medical specialties
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
Forms and how it is given
| Dosage forms | Tablet, film coated · Injection, powder, lyophilized, for solution |
|---|---|
| Route | Oral · Intravenous |
| Prescription products | 2 in the FDA NDC Directory |
| Brand names | Nuzyra |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Paratek Pharmaceuticals, Inc.2 products
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA209816 NUZYRA | Paratek Pharms | October 2, 2018 | 9, latest May 13, 2026 2026: Efficacy · 2025: Labeling · 2021: Efficacy |
| NDA209817 NUZYRA | Paratek Pharms | October 2, 2018 | 9, latest May 13, 2026 2026: Efficacy · 2025: Labeling · 2021: Efficacy |
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 2059274, 2059280, 2059288, 2059292 |
|---|---|
| SPL set ID of the quoted label | 51591524-4703-44c6-8bde-dce3e6a463d1 |
| FDA labels (SPL) | 1 |
| FDA applications | NDA209816, NDA209817 |
| Active ingredients (FDA) | OMADACYCLINE |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Nuzyra, Paratek Pharmaceuticals, Inc., effective May 27, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →